文摘
We have discovered and demonstrated the in?vitro and in?vivo PPAR¦Ä-selective activity of novel Y-shaped agonists. These compounds activated hPPAR¦Ä with EC50 values between 1 and 523?nM. Surprisingly, compounds 10a, 11d, 11e and 11f were the most potent and most selective hPPAR¦Ä agonists with 104-fold selectivity over the other two subtypes, namely, hPPAR¦Á and hPPAR¦Ã. The PPAR¦Ä ligands 10a, 11e and 11f showed good bioavailability and in?vivo efficacy.